TGFB1 and neoplasm: This might reflect an increased capacity of αvβ6-expressing tumor cells to migrate in a fibronectin-rich extra cellular matrix (ECM) and/or to activate TGF-β1 at the tumor/stroma interface, both of which processes may contribute to cervical cancer progression (Hazelbag et al., 2007).